The Special Adviser to the President on Health, Dr Salma Anas-Ibrahim, has expressed support for local vaccine production and believes it aligns with President Bola Ahmed Tinubu’s government’s priorities.

Anas-Ibrahim, said this when Dr Simon Agwale, CEO of Innovative Biotech, Nigeria and Innovative Biotech USA Inc, and other management staff paid her a courtesy visit.

The Special Adviser to the President on Health, Dr Salma Anas-Ibrahim, has expressed support for local vaccine production and believes it aligns with President Bola Ahmed Tinubu’s government’s priorities.

Anas-Ibrahim, said this when Dr Simon Agwale, CEO of Innovative Biotech, Nigeria and Innovative Biotech USA Inc, and other management staff paid her a courtesy visit.

A vaccinologist and virologist, Dr Simon Agwale, Tuesday, said that the local vaccine manufacturing initiative which his company, Innovative Biotech Limited, is constructing in Abuja, in partnership with Merck in Germany, will boost Nigeria’s capacity in combating emerging global diseases.

With the proven cases of people who were vaccinated against Covid-19 getting infected, a virologist and vaccinologist, Dr Simon Agwale, weekend, said the limitations of SARS-CoV-2 vaccines point towards the need for second-generation vaccines which would induce ‘more broadly protective and more durable immunity’.

Merck, a leading science and technology company, today announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the first vaccine production facility in Nigeria.